Skip to main content

Hahn Mark W

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Hahn Mark W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

VRNA Verona Pharma plc

Chief Financial Officer26 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 3, 2021 (view filing)Aug 21 dayHahn Mark WChief Financial OfficerSSale−10.4K$0.77−$8.02K−0.1%16.5M after
Nov 3, 2021 (view filing)Nov 21 dayHahn Mark WChief Financial OfficerSSale−10.4K$0.65−$6.77K−0.1%16.0M after
Feb 3, 2022 (view filing)Feb 21 dayHahn Mark WChief Financial OfficerSSale−10.4K$0.76−$7.92K−0.1%15.8M after
May 5, 2022 (view filing)May 32 daysHahn Mark WChief Financial OfficerSSale−12.5K$0.50−$6.26K−0.1%15.4M after
Aug 3, 2022 (view filing)Aug 12 daysHahn Mark WChief Financial OfficerSSale−13.2K$0.70−$9.22K−0.1%14.9M after
Aug 11, 2022 (view filing)Aug 92 daysHahn Mark WChief Financial OfficerSSale−600.0K$1.75−$1.05M−4.0%14.3M after
Nov 3, 2022 (view filing)Nov 12 daysHahn Mark WChief Financial OfficerSSale−13.2K$1.67−$22.0K−0.1%17.4M after
Dec 21, 2022 (view filing)Dec 201 dayHahn Mark WChief Financial OfficerSSale−600.0K$2.12−$1.27M−3.4%16.8M after
Feb 3, 2023 (view filing)Feb 12 daysHahn Mark WChief Financial OfficerSSale−413.2K$2.56−$1.06M−2.5%16.4M after
May 3, 2023 (view filing)May 12 daysHahn Mark WChief Financial OfficerSSale−455.5K$2.58−$1.18M−2.8%16.0M after10b5-1

See all 26 trades at VRNA